Picture of Novakand Pharma AB logo

NOVKAN — Novakand Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Kancera Q3 operating loss widens to SEK 16.6 million

Nov 17 (Reuters) - KANCERA AB  KANC.ST  
    * Q3 OPERATING LOSS SEK 16.6 MILLION VERSUS LOSS SEK 5.2 
MILLION 
YEAR AGO 
 
Source text for Eikon:  ID:nWkr5BGtPD  
Further company coverage:  KANC.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Novakand Pharma AB

See all news